NASDAQ:ATRC

Atricure Stock Insider Trading

Healthcare > Medical - Instruments & Supplies

Buy ATRC

*Your capital is at risk

$37.76

-2.39 (-5.95%)

At Close: Jul 31, 2026

AtriCure Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -24.07. In total, the insiders bought 728.03K and sold 323.93K ATRC shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-24.07
● Buy	728.03K shares
● Sell	323.93K shares
65% Buy Activity Negligible or No Correlation
Sell Signal Medium Confidence Jul 28, 2026 Analysis Breakdown: Supported by a negative Insider Power Score of -24.07. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Aug 05, 2025 Sell	Common Stock S-Sale	Doraiswamy Vinayak Chief Scientific Officer	Officer	2 500 Value: $91.5K
Aug 05, 2025 Sell	Common Stock S-Sale	Doraiswamy Vinayak Chief Scientific Officer	Officer	2 500 Value: $91.5K
Jun 30, 2025 Buy	Common Stock A-Award	Seith Douglas J Chief Operating Officer	C-Suite Officer	550 Value: $14.2K
Jun 30, 2025 Buy	Common Stock A-Award	Doraiswamy Vinayak Chief Scientific Officer	Officer	822 Value: $21.2K
Jun 30, 2025 Buy	Common Stock A-Award	Privitera Salvatore Chief Technical Officer	Officer	822 Value: $21.2K
Jun 30, 2025 Buy	Common Stock A-Award	Carrel Michael H President, CEO, & Director	CEO / President	822 Value: $21.2K
Jun 30, 2025 Buy	Common Stock A-Award	Dahlquist Karl S. Chief Legal Officer	Officer	822 Value: $21.2K
Jun 30, 2025 Buy	Common Stock A-Award	Dahlquist Karl S. Chief Legal Officer	Officer	822 Value: $21.2K
Jun 30, 2025 Buy	Common Stock A-Award	Carrel Michael H President, CEO, & Director	CEO / President	822 Value: $21.2K
Jun 30, 2025 Buy	Common Stock A-Award	Privitera Salvatore Chief Technical Officer	Officer	822 Value: $21.2K
Jun 30, 2025 Buy	Common Stock A-Award	Doraiswamy Vinayak Chief Scientific Officer	Officer	822 Value: $21.2K
Jun 30, 2025 Buy	Common Stock A-Award	Seith Douglas J Chief Operating Officer	C-Suite Officer	550 Value: $14.2K
May 28, 2025 Sell	Common Stock S-Sale	Doraiswamy Vinayak Chief Scientific Officer	Officer	2 500 Value: $83.6K
May 28, 2025 Sell	Common Stock S-Sale	Doraiswamy Vinayak Chief Scientific Officer	Officer	2 500 Value: $83.6K
May 19, 2025 Buy	Common Stock A-Award	Yuen Maggie Director	Director	5 401 Value: $175.0K
May 19, 2025 Buy	Common Stock A-Award	White Robert S. Director	Director	5 401 Value: $175.0K
May 19, 2025 Buy	Common Stock A-Award	Prange Karen Director	Director	5 401 Value: $175.0K
May 19, 2025 Buy	Common Stock A-Award	Nachman Shlomo Director	Director	5 401 Value: $175.0K
May 19, 2025 Buy	Common Stock A-Award	Johnson B Kristine Director	Director	5 401 Value: $175.0K
May 19, 2025 Buy	Common Stock A-Award	Wehrwein Sven Director	Director	5 401 Value: $175.0K
May 19, 2025 Buy	Common Stock A-Award	Telman Deborah H Director	Director	5 401 Value: $175.0K
May 19, 2025 Buy	Common Stock A-Award	Groves Regina E Director	Director	5 401 Value: $175.0K
May 19, 2025 Buy	Common Stock A-Award	Nachman Shlomo Director	Director	5 401 Value: $175.0K
May 19, 2025 Buy	Common Stock A-Award	Prange Karen Director	Director	5 401 Value: $175.0K
May 19, 2025 Buy	Common Stock A-Award	White Robert S. Director	Director	5 401 Value: $175.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ATRICURE

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform tem...

Read Full Profile Here